Piedad Arazo

Role of Weight-Based Ribavirin Dosing and Extended Duration of Therapy in Chronic Hepatitis C in HIV-Infected Patients: The PRESCO Trial

Marina Núñez, Celia Miralles, Miguel Angel Berdún et al. · AIDS Research and Human Retroviruses · 2007 · 189 citations

Pharmacy, Pharmacology, Pharmacotherapy +14

Lopinavir-Ritonavir Monotherapy Versus Lopinavir-Ritonavir and 2 Nucleosides for Maintenance Therapy of HIV: 96-Week Analysis

José Ramón Arribas, Rafaël Delgado, Alberto Arranz et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2009 · 108 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Dual Therapy With Darunavir and Ritonavir Plus Lamivudine vs Triple Therapy With Darunavir and Ritonavir Plus Tenofovir Disoproxil Fumarate and Emtricitabine or Abacavir and Lamivudine for Maintenance of Human Immunodeficiency Virus Type 1 Viral Suppression: Randomized, Open-Label, Noninferiority DUAL-GESIDA 8014-RIS-EST45 Trial

Federico Pulido, Esteban Ribera, María Lagarde et al. · Clinical Infectious Diseases · 2017 · 102 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Low-Level Viremia Is Associated With Clinical Progression in HIV-Infected Patients Receiving Antiretroviral Treatment

Enrique Bernal, José María Pérez Gómez, Inmaculada Jarrín et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2018 · 80 citations

Veterinary Medicine, Infectious Diseases, Clinical Epidemiology +11

Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study

Sergio Serrano‐Villar, Javier Martínez‐Sanz, Raquel Ron et al. · The Lancet HIV · 2020 · 70 citations · Full text

Public Health, Immunology, Infectious Diseases +8